DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Bimekizumab, Atc L04ac21 (Obo) for the Period October 1St, 2024 - September 30Th, 2026. The project location is Germany and the tender is closing on 05 Aug 2026. The tender notice number is -, while the TOT Ref Number is 106013128.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Bimekizumab, Atc L04ac21 (Obo) for the Period October 1St, 2024 - September 30Th, 2026
Sign in with Google